Preliminary analysis of association of m<sup>7</sup>G methyltransferase 1 with pan-cancer prognosis and immune infiltration

Objective To investigate the expression of RNA m<sup>7</sup>G methyltransferase 1 (METTL1) in various types of tumors and its association with prognosis and immune infiltration, in order to provide a new reference for the screening of cancer biomarkers and their mechanisms of occurrence...

Full description

Saved in:
Bibliographic Details
Main Authors: CHENG Wenli, FU Jiaqi, ZHU Chenyu, ZHANG Xinyu, TAN Luyi, ZHANG Wenjuan
Format: Article
Language:zho
Published: Editorial Office of Journal of Guangxi Medical University 2024-07-01
Series:Guangxi Yike Daxue xuebao
Subjects:
Online Access:https://journal.gxmu.edu.cn/article/doi/10.16190/j.cnki.45-1211/r.2024.07.003
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850035563054235648
author CHENG Wenli
FU Jiaqi
ZHU Chenyu
ZHANG Xinyu
TAN Luyi
ZHANG Wenjuan
author_facet CHENG Wenli
FU Jiaqi
ZHU Chenyu
ZHANG Xinyu
TAN Luyi
ZHANG Wenjuan
author_sort CHENG Wenli
collection DOAJ
description Objective To investigate the expression of RNA m<sup>7</sup>G methyltransferase 1 (METTL1) in various types of tumors and its association with prognosis and immune infiltration, in order to provide a new reference for the screening of cancer biomarkers and their mechanisms of occurrence and development. Methods The Cancer Genome Atlas (TCGA) was used to analyze the mRNA expression profile of METTL1 in 33 tumors and the differences in METTL1 expression between the tumor group and the normal control group. Cox regression model and Kaplan-Meier were used to analyze the correlation between METTL1 expression and the prognosis of cancer patients. The association between METTL1 expression and immune infiltration in liver hepatocellular carcinoma (LIHC) was analyzed, and the mRNA expression levels of METTL1 and immune checkpoint in normal hepatocytes and LIHC cells were preliminatively verified by fluorescence quantitative PCR. Results The expression level of METTL1 was different between cancer tissues and adjacent tissues, and it was highly expressed in most cancer tissues. High expression of METTL1 significantly shortened the median survival time of patients with low grade glioma (LGG), LIHC and mesothelioma (MESO). The expression level of METTL1 in LIHC was positively correlated with the levels of multiple inflammatory cells. And the expression level of METTL1 was positively correlated with the expression of immune checkpoints LAG3 and PDCD1 (P<0.001), which was consistent with the mRNA expression level in cultured LIHC cells in vitro. Conclusion METTL1 significantly promotes the occurrence and progression of most tumors, negatively regulates the prognosis survival rate of LGG, LIHC and MESO patients, and is positively correlated with immune infiltration. METTL1 is expected to be a cancer biomarker based on LAG3 and PDCD1 immunotherapy.
format Article
id doaj-art-6387939c6f8348ec8ff0f11c642ea302
institution DOAJ
issn 1005-930X
language zho
publishDate 2024-07-01
publisher Editorial Office of Journal of Guangxi Medical University
record_format Article
series Guangxi Yike Daxue xuebao
spelling doaj-art-6387939c6f8348ec8ff0f11c642ea3022025-08-20T02:57:28ZzhoEditorial Office of Journal of Guangxi Medical UniversityGuangxi Yike Daxue xuebao1005-930X2024-07-0141795996610.16190/j.cnki.45-1211/r.2024.07.00320240703Preliminary analysis of association of m<sup>7</sup>G methyltransferase 1 with pan-cancer prognosis and immune infiltrationCHENG Wenli0FU Jiaqi1ZHU Chenyu2ZHANG Xinyu3TAN Luyi4ZHANG Wenjuan5School of Medicine, Jinan University, Guangzhou 510632, ChinaSchool of Medicine, Jinan University, Guangzhou 510632, ChinaSchool of Medicine, Jinan University, Guangzhou 510632, ChinaSchool of Medicine, Jinan University, Guangzhou 510632, ChinaSchool of Medicine, Jinan University, Guangzhou 510632, ChinaSchool of Medicine, Jinan University, Guangzhou 510632, ChinaObjective To investigate the expression of RNA m<sup>7</sup>G methyltransferase 1 (METTL1) in various types of tumors and its association with prognosis and immune infiltration, in order to provide a new reference for the screening of cancer biomarkers and their mechanisms of occurrence and development. Methods The Cancer Genome Atlas (TCGA) was used to analyze the mRNA expression profile of METTL1 in 33 tumors and the differences in METTL1 expression between the tumor group and the normal control group. Cox regression model and Kaplan-Meier were used to analyze the correlation between METTL1 expression and the prognosis of cancer patients. The association between METTL1 expression and immune infiltration in liver hepatocellular carcinoma (LIHC) was analyzed, and the mRNA expression levels of METTL1 and immune checkpoint in normal hepatocytes and LIHC cells were preliminatively verified by fluorescence quantitative PCR. Results The expression level of METTL1 was different between cancer tissues and adjacent tissues, and it was highly expressed in most cancer tissues. High expression of METTL1 significantly shortened the median survival time of patients with low grade glioma (LGG), LIHC and mesothelioma (MESO). The expression level of METTL1 in LIHC was positively correlated with the levels of multiple inflammatory cells. And the expression level of METTL1 was positively correlated with the expression of immune checkpoints LAG3 and PDCD1 (P<0.001), which was consistent with the mRNA expression level in cultured LIHC cells in vitro. Conclusion METTL1 significantly promotes the occurrence and progression of most tumors, negatively regulates the prognosis survival rate of LGG, LIHC and MESO patients, and is positively correlated with immune infiltration. METTL1 is expected to be a cancer biomarker based on LAG3 and PDCD1 immunotherapy.https://journal.gxmu.edu.cn/article/doi/10.16190/j.cnki.45-1211/r.2024.07.003methyltransferase 1pan-cancerimmune infiltrationbiomarkerprognosis
spellingShingle CHENG Wenli
FU Jiaqi
ZHU Chenyu
ZHANG Xinyu
TAN Luyi
ZHANG Wenjuan
Preliminary analysis of association of m<sup>7</sup>G methyltransferase 1 with pan-cancer prognosis and immune infiltration
Guangxi Yike Daxue xuebao
methyltransferase 1
pan-cancer
immune infiltration
biomarker
prognosis
title Preliminary analysis of association of m<sup>7</sup>G methyltransferase 1 with pan-cancer prognosis and immune infiltration
title_full Preliminary analysis of association of m<sup>7</sup>G methyltransferase 1 with pan-cancer prognosis and immune infiltration
title_fullStr Preliminary analysis of association of m<sup>7</sup>G methyltransferase 1 with pan-cancer prognosis and immune infiltration
title_full_unstemmed Preliminary analysis of association of m<sup>7</sup>G methyltransferase 1 with pan-cancer prognosis and immune infiltration
title_short Preliminary analysis of association of m<sup>7</sup>G methyltransferase 1 with pan-cancer prognosis and immune infiltration
title_sort preliminary analysis of association of m sup 7 sup g methyltransferase 1 with pan cancer prognosis and immune infiltration
topic methyltransferase 1
pan-cancer
immune infiltration
biomarker
prognosis
url https://journal.gxmu.edu.cn/article/doi/10.16190/j.cnki.45-1211/r.2024.07.003
work_keys_str_mv AT chengwenli preliminaryanalysisofassociationofmsup7supgmethyltransferase1withpancancerprognosisandimmuneinfiltration
AT fujiaqi preliminaryanalysisofassociationofmsup7supgmethyltransferase1withpancancerprognosisandimmuneinfiltration
AT zhuchenyu preliminaryanalysisofassociationofmsup7supgmethyltransferase1withpancancerprognosisandimmuneinfiltration
AT zhangxinyu preliminaryanalysisofassociationofmsup7supgmethyltransferase1withpancancerprognosisandimmuneinfiltration
AT tanluyi preliminaryanalysisofassociationofmsup7supgmethyltransferase1withpancancerprognosisandimmuneinfiltration
AT zhangwenjuan preliminaryanalysisofassociationofmsup7supgmethyltransferase1withpancancerprognosisandimmuneinfiltration